The presence of an ATP7B variant significantly amplifies the risk of developing AT-DILI when combined with the NAT2 UA genotype, as more than 90% of individuals with these combined genotypes are likely to develop AT-DILI. This evidence concerns the gene ATP7B and ataxia telangiectasia.